130 related articles for article (PubMed ID: 34056976)
1. Involvement of Nestin in the Progression of Canine Mammary Carcinoma.
Yoshimura H; Moriya M; Yoshida A; Yamamoto M; Machida Y; Ochiai K; Michishita M; Nakagawa T; Matsuda Y; Takahashi K; Kamiya S; Ishiwata T
Vet Pathol; 2021 Sep; 58(5):994-1003. PubMed ID: 34056976
[TBL] [Abstract][Full Text] [Related]
2. Expression and Roles of S100A4 in Anaplastic Cells of Canine Mammary Carcinomas.
Yoshimura H; Otsuka A; Michishita M; Yamamoto M; Ashizawa M; Zushi M; Moriya M; Azakami D; Ochiai K; Matsuda Y; Ishiwata T; Kamiya S; Takahashi K
Vet Pathol; 2019 May; 56(3):389-398. PubMed ID: 30686112
[TBL] [Abstract][Full Text] [Related]
3. A role of ghrelin in canine mammary carcinoma cells proliferation, apoptosis and migration.
Majchrzak K; Pawłowski KM; Orzechowska EJ; Dolka I; Mucha J; Motyl T; Król M
BMC Vet Res; 2012 Sep; 8():170. PubMed ID: 22999388
[TBL] [Abstract][Full Text] [Related]
4. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
[TBL] [Abstract][Full Text] [Related]
5. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
6. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
[TBL] [Abstract][Full Text] [Related]
9. Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland.
Yoshimura H; Nakahira R; Kishimoto TE; Michishita M; Ohkusu-Tsukada K; Takahashi K
Vet Pathol; 2014 Nov; 51(6):1090-5. PubMed ID: 24448671
[TBL] [Abstract][Full Text] [Related]
10. The expression of intermediate filaments in canine mammary glands and their tumors.
Hellmén E; Lindgren A
Vet Pathol; 1989 Sep; 26(5):420-8. PubMed ID: 2555958
[TBL] [Abstract][Full Text] [Related]
11. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.
Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K
Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797
[TBL] [Abstract][Full Text] [Related]
14. Canine Mammary Carcinoma With Vacuolated Cytoplasm: Glycogen-Rich Carcinoma, a Histological Type Distinct From Lipid-Rich Carcinoma.
Muscatello LV; Papa V; Millanta F; Sarli G; Bacci B; Cenacchi G; Poli A; Giudice C; Brunetti B
Vet Pathol; 2021 Jan; 58(1):63-70. PubMed ID: 33205712
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
17. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
18. Protease-Activated Receptor-2 Is Associated With Adverse Outcomes in Canine Mammary Carcinoma.
Kaji K; Kaji N; Hori M; Sakai K; Yonezawa T; Maeda S
Vet Pathol; 2021 Jan; 58(1):53-62. PubMed ID: 33054598
[TBL] [Abstract][Full Text] [Related]
19. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
20. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
Delgado L; Gärtner F; Dias Pereira P
J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
